Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

UNEEG medical A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.1% 22.3% 5.3% 6.3% 7.7% 6.4% 16.4% 16.4%   Credit score (0-100)   21 4 41 37 30 37 11 11   Credit rating   BB B BBB BBB BB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -12,695 -32,356 -30,325 -45,136 -57,765 -49,863 0.0 0.0   EBITDA   -37,797 -62,037 -77,613 -107,863 -132,658 -130,775 0.0 0.0   EBIT   -38,217 -79,890 -95,809 -135,265 -165,289 -135,568 0.0 0.0   Pre-tax profit (PTP)   -44,447.0 -91,467.0 -112,786.0 -145,347.0 -181,392.0 -147,054.0 0.0 0.0   Net earnings   -34,277.0 -68,500.0 -88,602.0 -111,566.0 -140,678.0 -111,103.0 0.0 0.0   Pre-tax profit without non-rec. items   -44,447 -91,467 -112,786 -145,347 -181,392 -147,054 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   739 1,217 14,712 16,185 13,855 9,267 0.0 0.0   Shareholders equity total   -59,641 -128,141 131,257 179,054 38,417 100,411 -38,500 -38,500   Interest-bearing liabilities   170,183 252,967 1,324 4,069 195,146 196,885 38,652 38,652   Balance sheet total (assets)   135,002 157,579 165,875 211,074 272,548 314,398 152 152   Net Debt   166,535 248,443 -3,862 -999 190,865 184,200 38,652 38,652     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -12,695 -32,356 -30,325 -45,136 -57,765 -49,863 0.0 0.0   Gross profit growth   0.0% -154.9% 6.3% -48.8% -28.0% 13.7% 0.0% 0.0%   Employees   25 39 66 86 107 104 0 0   Employee growth %   0.0% 56.0% 69.2% 30.3% 24.4% -2.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   135,002 157,579 165,875 211,074 272,548 314,398 152 152   Balance sheet change%   0.0% 16.7% 5.3% 27.2% 29.1% 15.4% -100.0% 0.0%   Added value   -37,797.0 -62,037.0 -77,613.0 -107,863.0 -137,887.0 -130,775.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   89,675 -13,649 4,522 -5,284 -2,995 10,884 -184,296 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   301.0% 246.9% 315.9% 299.7% 286.1% 271.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -19.6% -33.3% -42.5% -74.4% -72.9% -45.6% 0.0% 0.0%   ROI %   -20.1% -34.5% -45.9% -84.2% -82.7% -50.0% 0.0% 0.0%   ROE %   -25.4% -46.8% -61.4% -71.9% -129.4% -160.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   -30.6% -44.8% 79.1% 84.8% 14.1% 31.9% -99.6% -99.6%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -440.6% -400.5% 5.0% 0.9% -143.9% -140.9% 0.0% 0.0%   Gearing %   -285.3% -197.4% 1.0% 2.3% 508.0% 196.1% -100.4% -100.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.3% 5.5% 13.3% 189.4% 5.2% 6.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.6 2.7 2.1 2.5 2.6 4.8 0.0 0.0   Current Ratio   0.7 2.8 2.5 3.0 3.0 5.9 0.0 0.0   Cash and cash equivalent   3,648.0 4,524.0 5,186.0 5,068.0 4,281.0 12,685.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -22,110.0 40,750.0 28,774.0 47,826.0 67,597.0 104,237.0 -19,326.0 -19,326.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -1,512 -1,591 -1,176 -1,254 -1,289 -1,257 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1,512 -1,591 -1,176 -1,254 -1,240 -1,257 0 0   EBIT / employee   -1,529 -2,048 -1,452 -1,573 -1,545 -1,304 0 0   Net earnings / employee   -1,371 -1,756 -1,342 -1,297 -1,315 -1,068 0 0